Future Prospects of Global Laboratory Proficiency Testing Market

Dengue fever, often known as breakbone fever, is a viral virus transmitted by mosquitos that causes a severe flu-like disease. Severe dengue fever is a potentially fatal consequence of the disease. Dengue vaccine is a human vaccine that prevents dengue disease.
Global Dengue Vaccine Market: Drivers
Over the forecast period, the worldwide
dengue vaccine market is expected to rise due to rising dengue
prevalence. According to the Pan American Health Organization, a total of
1,191,815 cases of dengue fever were recorded in the Americas region between
epidemiological weeks 1 and 22 of 2019, with 546,589 cases being
laboratory-confirmed and 5,599 being categorised as severe dengue.
Furthermore, market expansion is
likely to be aided by R&D of live attenuated vaccines. Dengvaxia, for
example, was licenced by the US Food and Drug Administration in May 2019 for
the prevention of dengue fever caused by all dengue virus serotypes. It's a chimaera
vaccine developed with recombinant DNA that's live attenuated and tetravalent.
Global Dengue Vaccine Market: Restraints
The market's growth is projected to be
hampered by the inability to distinguish dengue fever from other febrile
disorders. The symptoms of mosquito-borne infections like Zika, chikungunya
virus infection, and dengue fever, for example, are extremely similar, making
diagnosis challenging.
Furthermore, the market's expansion is
projected to be hampered by a lack of understanding of the pathophysiology of
dengue infection and a lack of appropriate animal models.
Global Dengue Vaccine Market: Opportunities
Dengue fever cases are predicted to
rise in metropolitan areas, providing lucrative growth prospects for market
players. In July 2018, researchers from the Bruno Kessler Foundation's Center
for Information Technology reported that the spread of dengue fever in a
non-endemic Brazilian metropolis was similar to a large dengue epidemic in
Cairns, Australia, where 95 percent of transmission events were localised
within the city.
Changes in dengue age trends are also
predicted to promote market growth. For example, researchers from Taipei
Medical University revealed in February 2018 that the rate of dengue infection
increased with age, and that females over the age of 40 had a higher infection
rate.
Comments
Post a Comment